Trials / Completed
CompletedNCT06390202
Uterine Artery Diastolic Notching & Apelin-13 and 36
Investigation of the Relationship Between Uterine Artery Doppler Diastolic Notching and Serum Apelin-13 and Apelin-36 Concentrations Between the 11th and 14th Weeks of Pregnancy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 88 (actual)
- Sponsor
- Umraniye Education and Research Hospital · Other Government
- Sex
- Female
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
This study was conducted to investigate the relationship between diastolic notching on uterine artery Doppler and serum apelin-13 and 36 concentrations between 11 and 14 weeks of gestation.
Detailed description
Apelin-13 and apelin-36, which provide vasodilatation through a nitric oxide-dependent mechanism, also play a role in trophoblasts' survival, proliferation, and migration. Based on this, we aimed to investigate serum apelin-13 and apelin-36 concentrations in pregnant women with and without diastolic notch on uterine artery Doppler between the 11th and 14th weeks of pregnancy. We hypothesized that apelin-13 and apelin-36 might be associated with the formation of diastolic notch in uterine artery Doppler and serum apelin-13 and apelin-36 concentrations would be lower in the group with a notch in the uterine artery Doppler than in the group without a notch.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention | there is no intervention in this study |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2023-10-30
- Completion
- 2024-01-01
- First posted
- 2024-04-30
- Last updated
- 2024-04-30
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06390202. Inclusion in this directory is not an endorsement.